ACER News and Press, Acer Therapeutics Inc. From 08/02/23

2023-08-02 06:04:22 ET Ares Commercial Real Estate press release ( ACRE ): Q2 GAAP EPS of $0.04. Revenue of $24.99M (-0.6% Y/Y). For further details see: Ares Commercial Real Estate GAAP EPS of $0.04, revenue of $24.99M

2023-06-26 12:39:40 ET Pharmaceutical company Acer Therapeutics ( NASDAQ: ACER ) said on Monday that CEO and Founder Christopher Schelling has infused $1M into the company in exchange for a promissory note. The company has issued a $1M unsecured, subordinated promissory n...

Promissory note extends cash runway into early Q3 2023 OLPRUVA™ expected to be available by prescription in the U.S. beginning July 5 th NEWTON, Mass., June 26, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company...

NEWTON, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial...

Availability: OLPRUVA™ drug in channel now anticipated in mid-June 2023 Awareness: 70% of metabolic treatment providers surveyed by Acer at SIMD Annual Meeting indicated an interest in treating at least one of their patients with OLPRUVA™ in 2023 Reimbursement: Ace...

2023-03-27 17:02:39 ET Acer Therapeutics press release ( NASDAQ: ACER ): Q4 GAAP EPS of -$0.54 misses by $0.17 . Ended Q4 2022 with $2.3 million in cash and cash equivalents. Acer believes its cash and cash equivalents available at December 31, 2022, together with the ...

NEWTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financi...

NEWTON, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today...

2023-03-22 08:12:30 ET Acer Therapeutics ( NASDAQ: ACER ) shares dropped 7% premarket on Wednesday after the pharmaceutical company announced a $2.675M securities offering priced at-the-market under Nasdaq rules. The offering comprises 2,920,306 shares of the company&#...

NEWTON, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today...